Daxxify, An Anti Wrinkle Treatment Approved In 2023
A study that was submitted to the Food and Drug Administration (FDA) in the United States showed that eighty percent of people receiving Daxxify saw no or mild facial lines within four months. The product is injected into the face along worry lines. As a result it was approved by the FDA for the reduction on facial wrinkles for approximately four months.
The manufacturer of Daxxify announced that the product is effective when injected along worry lines and lasted longer than other products on the market. Currently the closest product is the popular Botox, which has been used for years by patients that are looking for non-invasive solutions to reduce the appearance of fine lines and wrinkles.
The studies that were submitted far exceeded the effect of a placebo with eighty percent of those receiving the treatment seeing mild or no facial lines within four months of having the injection and half saw effects through to six months. This product is the most significant advancement in facial injection drugs since Botox. Botox currently dominates seventy percent of the market since being approved decades ago.
Most people live busy lifestyles and currently, those that receive Botox need to have injections every three months. The new product offers a longer duration, helping to save patients time and energy. The product is backed by years of research and testing to find an agent that could be applied without a needle. In the process they found a way to keep the formula stable using peptide technology. This has resulted in the products approved, opening up doors for what it can do with therapeutics.”
Dr Jaymi Lad, the Co Founder and Medical Director of Javivo, a Manchester, United Kingdom based skin care specialist, said “Botox was originally approved to treat chronic migraines. While the FDA has warned on potential side effects when using a toxin based treatment, no such symptoms were noted using Daxxify.”
it has not been an easy task to get Daxxify approved. The company hoped for approved in November 2020 but was postponed due to the coronavirus travel restrictions. In 2021, there were problems identified in the company’s quality control processes. All this has been resolved to introduce a competitor to Botox that could be making its way to the United Kingdom shortly.
About Us:
Javivo is a doctor-led, non-surgical skin and beauty clinic based in the heart of Manchester in the United Kingdom. The clinic provides a complete range of skin and beauty treatments that are safe, using hand sourced products from reliable supplies. They offer a safe environment with fully qualified and insured doctors that clients can trust.
Javivo offers chemical peels, dermal fillers, medical skincare treatments, laser hair removal and more with a choice of packages available. They are open six days a week until late, ensuring that their clients can secure an appointment at a time convenient for them. Full details can be found on their information packed website.
Summary
An anti wrinkle treatment, Daxxify, has been approved for human use in 2023.
Source
Javivo Clinic
Leave a Reply
You must be logged in to post a comment.